For practitioners
Prescribe with confidence. The data backs it.
A patented dermocosmetic platform anchored by ECMT-154 - placebo-controlled, dermatologist-evaluated, and built for daily use alongside your clinical protocols.
30%Sebum reduction - 28 days
79%Pustule reduction - derm-evaluated
100%Safe to use
ECMT-154
Backed by science. Powered by nature.
A proprietary therapeutic extract derived from high-triketone manuka oil (East Cape, NZ) and palmarosa, developed by Manuka Bioscience and refined for clinical use.
- Antimicrobial profile validated against C. acnes, S. epidermidis, S. aureus and MRSA
- Anti-inflammatory action - inhibits TNF-a and IL-1b in keratinocyte assays
- Collagen-stimulating: 6x more Type I and 3x more Type III collagen than standard Vitamin C
- Hypoallergenic - 0% reactive irritation across 51 subjects (Eurofins HRIPT)
- Suitable for pre- and post-procedural care alongside laser, peel and microneedling protocols
Clinical tests
Clinically tested. Dermatologist trusted.
Rejencia's Manuka Ritual Blemish Kit was evaluated head-to-head against placebo in a 14- and 28-day independent trial using DermaLab Combo, ASW 300 and NATI V3 (SKINLAB P.S.A. Laboratory).
Partner with Rejencia.
Distributor enquiries, clinical-trial collaborations, and retail partnerships welcome. We currently support 7,000+ doctors and 360 clinics across North America.